Brief: Chemocentryx Reports Qtrly Loss Per Share Of $0.43

Churchill Capital XI

01/03/2021 21:37

March 1 (Reuters) - ChemoCentryx Inc  CCXI.O :
    * CHEMOCENTRYX REPORTS FOURTH QUARTER AND FULL YEAR 2020
FINANCIAL
RESULTS AND RECENT HIGHLIGHTS
    * Q4 REVENUE $4.4 MILLION VERSUS $10 MILLION
    * Q4 REVENUE ESTIMATE $8 MILLION -- REFINITIV IBES DATA
    * $460 MILLION IN CASH AND INVESTMENTS AT YEAR END 2020
    * EXPECTS TO UTILIZE CASH, CASH EQUIVALENTS AND INVESTMENTS
IN THE
RANGE OF $145 MILLION TO $155 MILLION IN 2021
    * QTRLY LOSS PER SHARE $0.43
    * Q4 EARNINGS PER SHARE VIEW $-0.33 -- REFINITIV IBES DATA

Source text for Eikon:  ID:nGNX7Ltmch 
Further company coverage:  CCXI.O 

 ((Reuters.Briefs@thomsonreuters.com;))